Adeline R. S.
- Country
- France
- Department
- Neurology
Research Overview
- Evaluation of Immune Response in Early Alzheimer's Disease Patients Treated with Posdinemab
- A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study with a Long-Term Extension Treatment Period to Assess the Efficacy and Safety of JNJ-63733657, an Anti-tau Monoclonal Antibody, in Participants with Early Alzheimer's Disease
- Efficacy, Safety, and Immunogenicity of JNJ-64042056 in Preclinical Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blind Study
Data & Insights
Has run more than one trial at 24 of 56 partner sites.
Specializations
Neurodegenerative Disorders
This investigator specializes in studying early-stage Alzheimer's disease, focusing on innovative therapeutic approaches and disease mechanisms.
- Early Alzheimer's Disease Detection
- Novel Treatment Evaluation
- Disease Progression Assessment
The investigator's work encompasses evaluating novel compounds and immune responses in Alzheimer's disease patients.
Immunological Research
The investigator conducts research on immune response characterization in neurodegenerative conditions, particularly in Alzheimer's disease contexts.
- Immune System Monitoring
- Therapeutic Response Assessment
- Immunological Biomarkers
Their work includes analyzing immune responses to therapeutic interventions in neurological disorders.
Clinical Pharmacology
Research interests include pharmacodynamics and pharmacokinetics of experimental treatments for neurodegenerative conditions.
- Drug Safety Assessment
- Therapeutic Tolerability
- Clinical Response Evaluation
The investigator evaluates safety profiles and therapeutic responses of novel compounds in clinical settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.